Bellevue Group Ag Hutchmed (China) LTD Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Bellevue Group Ag holds 24,015 shares of HCM stock, worth $322,281. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,015

Previous 1,149,157 97.91%

Holding current value

$322,281

Previous $19.7 Million 97.62%

% of portfolio

0.01%

Previous 0.33%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.03 - $20.31 $18 Million - $22.9 Million	-1,125,142 Reduced 97.91%	24,015 $469,000
Q2 2024 Aug 14, 2024	SELL	$16.36 - $21.78 $89,571 - $119,245	-5,475 Reduced 0.47%	1,149,157 $19.7 Million
Q1 2024 May 15, 2024	BUY	$12.08 - $18.56 $284,133 - $436,549	23,521 Added 2.08%	1,154,632 $19.4 Million
Q4 2023 Feb 14, 2024	SELL	$16.25 - $20.23 $10.9 Million - $13.6 Million	-671,852 Reduced 37.26%	1,131,111 $20.5 Million
Q3 2023 Nov 14, 2023	SELL	$11.85 - $16.95 $31,047 - $44,409	-2,620 Reduced 0.15%	1,802,963 $30.5 Million
Q2 2023 Aug 14, 2023	SELL	$10.78 - $17.73 $230,551 - $379,191	-21,387 Reduced 1.17%	1,805,583 $21.7 Million
Q1 2023 May 15, 2023	BUY	$13.02 - $19.87 $609,674 - $930,432	46,826 Added 2.63%	1,826,970 $23.8 Million
Q4 2022 Feb 14, 2023	BUY	$7.65 - $15.51 $168,827 - $342,290	22,069 Added 1.26%	1,780,144 $26.3 Million
Q3 2022 Nov 14, 2022	BUY	$8.63 - $15.52 $15,257 - $27,439	1,768 Added 0.1%	1,758,075 $15.9 Million
Q2 2022 Aug 11, 2022	BUY	$8.59 - $20.77 $48,250 - $116,665	5,617 Added 0.32%	1,756,307 $21.4 Million
Q1 2022 May 13, 2022	BUY	$15.52 - $35.65 $10.5 Million - $24 Million	673,820 Added 62.57%	1,750,690 $33.1 Million
Q4 2021 Feb 10, 2022	BUY	$28.89 - $35.33 $2.04 Million - $2.5 Million	70,723 Added 7.03%	1,076,870 $37.8 Million
Q3 2021 Nov 12, 2021	BUY	$35.66 - $42.94 $5.04 Million - $6.07 Million	141,387 Added 16.35%	1,006,147 $36.8 Million
Q2 2021 Aug 12, 2021	SELL	$23.7 - $39.27 $2.62 Million - $4.35 Million	-110,728 Reduced 11.35%	864,760 $34 Million
Q1 2021 May 12, 2021	BUY	$27.01 - $36.8 $751,256 - $1.02 Million	27,814 Added 2.93%	975,488 $27.6 Million
Q2 2020 Aug 13, 2020	BUY	$17.65 - $28.05 $1.69 Million - $2.68 Million	95,680 Added 11.23%	947,674 $26.1 Million
Q1 2020 May 14, 2020	BUY	$15.19 - $29.51 $519,148 - $1.01 Million	34,177 Added 4.18%	851,994 $15.2 Million
Q4 2019 Feb 14, 2020	BUY	$17.17 - $25.95 $508,558 - $768,613	29,619 Added 3.76%	817,817 $20.5 Million
Q3 2019 Nov 14, 2019	BUY	$17.84 - $22.69 $3.39 Million - $4.31 Million	189,888 Added 31.74%	788,198 $13.8 Million
Q1 2019 May 15, 2019	BUY	$21.27 - $30.58 $3.36 Million - $4.84 Million	158,141 Added 35.93%	598,310 $18.3 Million
Q4 2018 Feb 12, 2019	BUY	$23.09 - $37.69 $926,832 - $1.51 Million	40,140 Added 10.03%	440,169 $10.2 Million
Q3 2018 Nov 13, 2018	BUY	$26.55 - $34.38 $1.79 Million - $2.32 Million	67,493 Added 20.3%	400,029 $12.9 Million
Q2 2018 Aug 07, 2018	BUY	$27.79 - $34.49 $836,923 - $1.04 Million	30,116 Added 9.96%	332,536 $10 Million
Q1 2018 May 09, 2018	BUY	$28.87 - $41.13 $4.87 Million - $6.93 Million	168,570 Added 125.94%	302,420 $8.94 Million
Q4 2017 Feb 14, 2018	BUY	$27.41 - $39.42 $1.9 Million - $2.73 Million	69,277 Added 107.28%	133,850 $5.26 Million
Q3 2017 Nov 13, 2017	BUY	$22.15 - $27.5 $782,581 - $971,602	35,331 Added 120.82%	64,573 $1.75 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,242	29,242 $682,000

Others Institutions Holding HCM

# of Institutions

Shares Held

6.74M

Call Options Held

6.2K

Put Options Held

1.1K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.32B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Hutchmed (China) LTD Transaction History